glucose, (beta-d)-isomer has been researched along with Coronary Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Banach, M; Barylski, M; Grycewicz, J; Irzmański, R; Kowalski, J; Pawlicki, L | 1 |
| Johnson, PJ; Kakita, C; Katz, LN; Pick, R | 1 |
| Aktas, G; Bilgin, S; Duman, TT; Erge, E; Kahveci, G; Kiran, M; Kurtkulagi, O; Tel, BMA | 1 |
| Wang, D; Wu, C; Yuan, L | 1 |
| Chang, YX; Chen, S; Ding, M; Gao, XM; Li, J; Li, Y; Ma, W; Mao, H; Wang, H; Wang, Q; Wang, X; Wei, J; Yang, X; Yang, Y; Zou, S | 1 |
| Du, MB; Hou, R; Liang, RX; Liu, SZ; Wang, L; Wang, YL; Zhang, JY | 1 |
| Bristot, L; Campo, G; Ferrari, R; Gambetti, S; Marchesini, J; Monti, M; Pavasini, R; Pollina, A | 1 |
2 trial(s) available for glucose, (beta-d)-isomer and Coronary Disease
| Article | Year |
|---|---|
Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention.
Topics: Adult; Atorvastatin; Coronary Disease; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins, LDL; Male; Middle Aged; Neutrophils; Primary Prevention; Pyrroles; Superoxides; Zymosan | 2006 |
The in vitro effects of verbascoside on human platelet aggregation.
Topics: Adenosine Diphosphate; Adult; Aged; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Blood Platelets; Coronary Disease; Female; Glucosides; Humans; Male; Middle Aged; Phenols; Platelet Aggregation | 2012 |
5 other study(ies) available for glucose, (beta-d)-isomer and Coronary Disease
| Article | Year |
|---|---|
The role of the reticuloendothelial system (RES) on blood lipid alterations and atherogenesis in cholesterol-oil fed and estrogen treated cockerels.
Topics: Animals; Arteriosclerosis; Cholesterol; Coronary Disease; Diet, Atherogenic; Dietary Fats; Estrogens, Conjugated (USP); Hypercholesterolemia; In Vitro Techniques; Lipids; Male; Mononuclear Phagocyte System; Poultry; Zymosan | 1966 |
Sodium glucose co-transporter-2 inhibitor, Empagliflozin, is associated with significant reduction in weight, body mass index, fasting glucose, and A1c levels in Type 2 diabetic patients with established coronary heart disease: the SUPER GATE study.
Topics: Benzhydryl Compounds; Blood Glucose; Body Mass Index; Coronary Disease; Diabetes Mellitus, Type 2; Fasting; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2022 |
Protective effect of liquiritin on coronary heart disease through regulating the proliferation of human vascular smooth muscle cells via upregulation of sirtuin1.
Topics: Atherosclerosis; Cell Proliferation; Cell Survival; Cells, Cultured; Coronary Disease; Cytoprotection; Flavanones; Gene Expression Regulation; Glucosides; Humans; Lipoproteins, LDL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protective Agents; Sirtuin 1; Up-Regulation | 2022 |
A network pharmacology integrated pharmacokinetics strategy for uncovering pharmacological mechanism of compounds absorbed into the blood of Dan-Lou tablet on coronary heart disease.
Topics: Abietanes; Administration, Oral; Animals; Chromatography, Liquid; Coronary Disease; Drugs, Chinese Herbal; Glucosides; Isoflavones; Male; Monoterpenes; Myocardium; Pharmacology; Phenanthrenes; Protein Interaction Maps; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2019 |
[Pharmacokinetic study on three main ingredients of refined coronary cataplasm].
Topics: Abietanes; Animals; Benzoates; Benzofurans; Bridged-Ring Compounds; Chromatography, Liquid; Coronary Disease; Drugs, Chinese Herbal; Glucosides; Humans; Male; Monoterpenes; Rabbits; Tandem Mass Spectrometry | 2012 |